Amino acid mutations in the env gp90 protein that modify N-linked glycosylation of the Chinese EIAV vaccine strain enhance resistance to neutralizing antibodies.

The research article explores how specific amino acid mutations in the env gp90 protein of the Chinese Equine Infectious Anaemia Virus (EIAV) vaccine strain enhance its resistance against neutralizing antibodies. The mutations led to the loss of three potential N-linked glycosylation sites and allowed the virus to successfully resist neutralization attempts.

Study Design and Methodology

• The researchers compared the env gene in the original, virulent horse virus (EIAV(L)) with attenuated strains that had undergone serial passage in donkey MDM (EIAV(DLV)), as well as donkey dermal cells (EIAV(FDDV)).
• Genetic comparisons were made between the original virus and attenuated strains to identify any changes in the sequence.
• The goal was to investigate any amino acid substitutions or deletions that resulted in the loss of potential N-linked glycosylation sites in the viral gp90 protein.

Key Findings

• The research discovered that the vaccine strains contained substitutions/deletions in gp90, leading to a loss of three potential N-linked glycosylation sites, labelled as g5, g9, and g10.
• It was found that these genetic mutations increased the virus’s resistance to neutralizing antibodies.
• Viruses with these mutations were still detectable by parental viruses, implying that the mutations did not affect the antigenic nature of the virus.

Methodological Detail on Reverse-Mutated Virus Construction

• To understand the biological significance of these mutations, the researchers created reverse-mutated viruses using the backbone of an infectious molecular clone EIAV(FDDV).
• The newly constructed virus stocks were then tested for replication efficiency within donkey dermal cells and donkey MDM.
• The mutated viruses were also assessed for sensitivity to neutralization using serum from ponies that had been experimentally infected with EIAV(FDDV).

Implications of the Findings

• The study findings suggest that the identified amino acid mutations play a critical role in attenuating the EIAV vaccine strains.
• In addition, these mutations significantly improve the resistance of the virus to neutralizing antibodies, potentially increasing the vaccine’s efficacy.
• This research provides direction for future vaccine design and development, with the potential for enhancing the effectiveness of existing vaccines.